These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1737333

  • 1. Infrequent p53 mutation in mouse tumors with deregulated myc.
    Gutierrez MI, Bhatia K, Siwarski D, Wolff L, Magrath IT, Mushinski JF, Huppi K.
    Cancer Res; 1992 Feb 15; 52(4):1032-5. PubMed ID: 1737333
    [Abstract] [Full Text] [Related]

  • 2. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
    Shaughnessy JD, Owens JD, Wiener F, Hilbert DM, Huppi K, Potter M, Mushinski JF.
    Oncogene; 1993 Nov 15; 8(11):3111-21. PubMed ID: 8414513
    [Abstract] [Full Text] [Related]

  • 3. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S.
    Cancer Res; 2005 Feb 15; 65(4):1306-15. PubMed ID: 15735016
    [Abstract] [Full Text] [Related]

  • 4. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
    Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I.
    Nat Genet; 1993 Sep 15; 5(1):56-61. PubMed ID: 8220424
    [Abstract] [Full Text] [Related]

  • 5. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS, Shaffer AL, Kim JS, duBois W, Potter M, Staudt LM, Janz S.
    Cancer Res; 2005 Sep 01; 65(17):7644-52. PubMed ID: 16140930
    [Abstract] [Full Text] [Related]

  • 6. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR, Janz S, Potter M.
    Cancer Res; 1995 Nov 01; 55(21):5012-8. PubMed ID: 7585544
    [Abstract] [Full Text] [Related]

  • 7. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
    Largaespada DA, Kaehler DA, Mishak H, Weissinger E, Potter M, Mushinski JF, Risser R.
    Oncogene; 1992 Apr 01; 7(4):811-9. PubMed ID: 1565479
    [Abstract] [Full Text] [Related]

  • 8. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V, Kopantzev E, Dertzbaugh M, Rudikoff S.
    Oncogene; 1997 Jun 26; 14(25):3011-6. PubMed ID: 9223664
    [Abstract] [Full Text] [Related]

  • 9. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 10. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S.
    Cancer Res; 2003 Dec 15; 63(24):8656-63. PubMed ID: 14695177
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
    Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, Kovalchuk AL, Fredrickson TN, Hartley JW, Roopenian DC, Davidson WF, Janz S, Morse HC.
    Cancer Res; 2007 Mar 15; 67(6):2439-47. PubMed ID: 17363561
    [Abstract] [Full Text] [Related]

  • 13. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE, Schröck E, Weaver Z, du Manoir S, Yang F, Ferguson-Smith MA, Ried T, Janz S.
    Cancer Res; 1997 Oct 15; 57(20):4585-92. PubMed ID: 9377573
    [Abstract] [Full Text] [Related]

  • 14. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
    Wiener F, Coleman A, Mock BA, Potter M.
    Cancer Res; 1995 Mar 01; 55(5):1181-8. PubMed ID: 7867005
    [Abstract] [Full Text] [Related]

  • 15. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P.
    Oncogene; 1995 Jul 06; 11(1):181-90. PubMed ID: 7624126
    [Abstract] [Full Text] [Related]

  • 16. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J, Wiener F, Huppi K, Mushinski JF, Potter M.
    Oncogene; 1994 Jan 06; 9(1):247-53. PubMed ID: 8302586
    [Abstract] [Full Text] [Related]

  • 17. Deletional remodeling of c-myc-deregulating chromosomal translocations.
    Kovalchuk AL, Müller JR, Janz S.
    Oncogene; 1997 Nov 06; 15(19):2369-77. PubMed ID: 9393881
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D, Thomas-Tikhonenko A.
    Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.